Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amarin - 32 Year Stock Price History | AMRN

Historical daily share price chart and data for Amarin since 1993 adjusted for splits and dividends. The latest closing stock price for Amarin as of July 30, 2025 is 14.97.
  • The all-time high Amarin stock closing price was 27500.00 on July 09, 1993.
  • The Amarin 52-week high stock price is 17.49, which is 16.8% above the current share price.
  • The Amarin 52-week low stock price is 7.08, which is 52.7% below the current share price.
  • The average Amarin stock price for the last 52 weeks is 11.53.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Amarin Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 11.6696 10.4720 17.3300 8.0020 14.9700 54.33%
2024 15.5530 17.7840 27.0000 8.8720 9.7000 -44.25%
2023 24.4838 23.8000 43.8000 13.2000 17.4000 -28.10%
2022 39.8223 70.2000 74.6000 21.4000 24.2000 -64.09%
2021 103.0901 100.6000 176.0000 64.8000 67.4000 -31.08%
2020 170.3802 430.6000 430.6000 72.8000 97.8000 -77.19%
2019 364.1571 260.2000 482.4000 252.2000 428.8000 57.53%
2018 144.3048 84.8000 459.6000 49.0000 272.2000 239.40%
2017 66.3661 61.8000 85.8000 57.4000 80.2000 30.19%
2016 46.8516 36.2000 69.4000 25.4000 61.6000 62.96%
2015 40.1429 22.6000 58.0000 20.0000 37.8000 92.92%
2014 30.3917 39.2000 48.0000 16.6460 19.5940 -50.27%
2013 118.2469 162.0000 183.2000 28.0000 39.4000 -75.65%
2012 221.6366 141.0000 309.2000 127.0000 161.8000 8.01%
2011 214.0792 166.6000 390.0000 120.6000 149.8000 -8.67%
2010 53.0791 27.6000 169.8000 19.6000 164.0200 473.54%
2009 23.8716 13.6000 39.0020 10.4000 28.5980 101.39%
2008 38.1171 50.0000 71.7980 12.0000 14.2000 -72.69%
2007 200.1849 436.0000 756.0000 45.0000 52.0000 -88.60%
2006 522.9477 270.0000 748.0000 254.0000 456.0000 90.00%
2005 358.4254 524.0000 680.8000 212.0000 240.0000 -55.72%
2004 277.9263 308.0000 798.0000 106.0000 542.0000 75.97%
2003 580.3368 788.0000 962.0000 278.0000 308.0000 -61.40%
2002 1685.8640 3420.0000 4200.0000 552.0000 798.0000 -77.04%
2001 2692.2460 1100.0000 5594.0000 1000.0000 3475.0000 215.91%
2000 1204.0249 900.0000 1556.2500 750.0000 1100.0000 15.79%
1999 1428.2570 887.5000 2275.0000 825.0000 950.0000 33.33%
1998 2096.1660 6125.0000 6125.0000 200.0000 712.5000 -88.60%
1997 10031.1192 11625.0000 13250.0000 5875.0000 6250.0000 -46.24%
1996 17057.8657 18000.0000 22500.0000 11000.0000 11625.0000 -35.42%
1995 14767.8167 13500.0000 20000.0000 10000.0000 18000.0000 38.46%
1994 15496.5475 17500.0000 21000.0000 9625.0000 13000.0000 -25.71%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.303B $0.229B
Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels. The FDA approved Vascepa to reduce cardiovascular risk in patients with persistent elevated triglycerides on statin therapy for LDL-C. The drug received approval for both indications in Europe under the tradename of Vazkepa. It has initiated various promotional activities and direct-to-consumer programs as well as expanded its salesforce to support promotion of Vascepa's expanded label. A generic version of Vascepa has been launched for elevated TG levels.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $229.437B 16.74
Amgen (AMGN) United States $163.226B 14.62
Gilead Sciences (GILD) United States $142.094B 14.76
Vertex Pharmaceuticals (VRTX) United States $120.286B 0.00
Bristol Myers Squibb (BMY) United States $95.364B 6.38
CSL (CSLLY) Australia $86.044B 0.00
GSK (GSK) United Kingdom $76.905B 9.23
Regeneron Pharmaceuticals (REGN) United States $60.260B 14.63
Alnylam Pharmaceuticals (ALNY) United States $43.100B 0.00
Argenex SE (ARGX) Netherlands $36.646B 99.80
BioNTech SE (BNTX) Germany $26.799B 0.00
Royalty Pharma (RPRX) United States $20.955B 8.85
Insmed (INSM) United States $19.920B 0.00
Biogen (BIIB) United States $18.741B 8.08
Illumina (ILMN) United States $17.209B 32.65
Incyte (INCY) United States $14.977B 19.25
Genmab (GNMSF) Denmark $14.683B 15.02
Genmab (GMAB) Denmark $14.499B 16.26
Moderna (MRNA) United States $12.631B 0.00
QIAGEN (QGEN) Netherlands $11.352B 22.09
BioMarin Pharmaceutical (BMRN) United States $11.167B 18.14
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $9.987B 0.00
Exelixis (EXEL) United States $9.944B 17.93
Bio-Techne Corp (TECH) United States $9.072B 33.84
Exact Sciences (EXAS) United States $8.968B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.953B 0.00
Roivant Sciences (ROIV) United Kingdom $7.763B 0.00
Legend Biotech (LEGN) United States $7.492B 0.00
Halozyme Therapeutics (HALO) United States $7.276B 13.93
Jazz Pharmaceuticals (JAZZ) Ireland $7.056B 6.93
Repligen (RGEN) United States $7.040B 76.87
Revolution Medicines (RVMD) United States $6.894B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.868B 0.00
Anbio Biotechnology (NNNN) Germany $6.779B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 23.40
Nuvalent (NUVL) United States $5.688B 0.00
TG Therapeutics (TGTX) United States $5.609B 147.21
Rhythm Pharmaceuticals (RYTM) United States $5.448B 0.00
Guardant Health (GH) United States $5.367B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.097B 0.00
Axsome Therapeutics (AXSM) United States $4.944B 0.00
Telix Pharmaceuticals (TLX) Australia $4.565B 0.00
Merus (MRUS) Netherlands $4.563B 0.00
Zai Lab (ZLAB) China $4.500B 0.00
Vaxcyte (PCVX) United States $4.474B 0.00
Alkermes (ALKS) Ireland $4.452B 12.39
Abivax SA (ABVX) France $4.430B 0.00
Krystal Biotech (KRYS) United States $4.395B 33.87
ADMA Biologics Inc (ADMA) United States $4.359B 32.61
Avidity Biosciences (RNA) United States $4.333B 0.00
Cytokinetics (CYTK) United States $4.287B 0.00
PTC Therapeutics (PTCT) United States $3.907B 6.80
Metsera (MTSR) United States $3.905B 0.00
Zealand Pharma (ZLDPF) Denmark $3.878B 0.00
Arcellx (ACLX) United States $3.857B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.787B 33.28
Akero Therapeutics (AKRO) United States $3.786B 0.00
Viking Therapeutics (VKTX) United States $3.701B 0.00
Scholar Rock Holding (SRRK) United States $3.539B 0.00
Ascentage Pharma Group - (AAPG) China $3.497B 0.00
Protagonist Therapeutics (PTGX) United States $3.410B 73.35
MoonLake Immunotherapeutics (MLTX) Switzerland $3.351B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.351B 0.00
Alvotech (ALVO) Luxembourg $2.930B 16.76
Bavarian Nordic (BVNRY) Denmark $2.881B 15.23
Immunovant (IMVT) United States $2.848B 0.00
Kymera Therapeutics (KYMR) United States $2.846B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.615B 0.00
Ligand Pharmaceuticals (LGND) United States $2.539B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.535B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.419B 0.00
Apellis Pharmaceuticals (APLS) United States $2.382B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.369B 0.00
ImmunityBio (IBRX) United States $2.242B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.216B 759.25
Arrowhead Pharmaceuticals (ARWR) United States $2.199B 0.00
Agios Pharmaceuticals (AGIO) United States $2.185B 0.00
IDEAYA Biosciences (IDYA) United States $2.176B 0.00
Twist Bioscience (TWST) United States $2.078B 0.00
Disc Medicine (IRON) United States $2.071B 0.00
Mesoblast (MESO) Australia $2.040B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.036B 13.53
Belite Bio (BLTE) United States $2.025B 0.00
Vericel (VCEL) United States $2.007B 1328.67
Beam Therapeutics (BEAM) United States $2.004B 0.00
CG Oncology (CGON) United States $1.985B 0.00
Denali Therapeutics (DNLI) United States $1.977B 0.00
Amicus Therapeutics (FOLD) United States $1.888B 204.33
Arcutis Biotherapeutics (ARQT) United States $1.787B 0.00
Apogee Therapeutics (APGE) United States $1.747B 0.00
Certara (CERT) United States $1.726B 32.24
Immunocore Holdings (IMCR) United Kingdom $1.703B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.686B 0.00
Liquidia Technologies (LQDA) United States $1.646B 0.00
Adaptive Biotechnologies (ADPT) United States $1.578B 0.00
Sarepta Therapeutics (SRPT) United States $1.556B 0.00
Celcuity (CELC) United States $1.498B 0.00
Edgewise Therapeutics (EWTX) United States $1.468B 0.00
Celldex Therapeutics (CLDX) United States $1.457B 0.00
Janux Therapeutics (JANX) United States $1.430B 0.00
AbCellera Biologics (ABCL) Canada $1.400B 0.00
ANI Pharmaceuticals (ANIP) United States $1.391B 14.33
Travere Therapeutics (TVTX) United States $1.379B 0.00
Viridian Therapeutics (VRDN) United States $1.370B 0.00
Cogent Biosciences (COGT) United States $1.348B 0.00
89BIO (ETNB) United States $1.346B 0.00
Dynavax Technologies (DVAX) United States $1.344B 79.93
Vera Therapeutics (VERA) United States $1.321B 0.00
Biohaven (BHVN) United States $1.310B 0.00
Intellia Therapeutics (NTLA) United States $1.295B 0.00
WAVE Life Sciences (WVE) Singapore $1.294B 0.00
NovoCure (NVCR) Jersey $1.272B 0.00
Cidara Therapeutics (CDTX) United States $1.249B 0.00
GRAIL (GRAL) United States $1.227B 0.00
CureVac (CVAC) Germany $1.214B 5.88
Jyong Biotech (MENS) Taiwan $1.191B 0.00
MannKind (MNKD) United States $1.161B 23.88
Praxis Precision Medicines (PRAX) United States $1.140B 0.00
Novavax (NVAX) United States $1.135B 2.65
Pharvaris (PHVS) Netherlands $1.025B 0.00
Structure Therapeutics (GPCR) United States $1.021B 0.00
Arcus Biosciences (RCUS) United States $1.018B 0.00
Spyre Therapeutics (SYRE) United States $1.011B 0.00
Sana Biotechnology (SANA) United States $1.003B 0.00
Pacira BioSciences (PCRX) United States $1.000B 9.52
MiMedx (MDXG) United States $0.985B 23.82
Iovance Biotherapeutics (IOVA) United States $0.975B 0.00
Anavex Life Sciences (AVXL) United States $0.970B 0.00
Zymeworks (ZYME) United States $0.941B 0.00
Oric Pharmaceuticals (ORIC) United States $0.941B 0.00
Immunome (IMNM) United States $0.922B 0.00
Nurix Therapeutics (NRIX) United States $0.909B 0.00
BGM Group (BGM) China $0.905B 0.00
Mineralys Therapeutics (MLYS) United States $0.905B 0.00
LENZ Therapeutics (LENZ) United States $0.891B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.891B 0.00
Trevi Therapeutics (TRVI) United States $0.886B 0.00
Urogen Pharma (URGN) United States $0.873B 0.00
Nuvation Bio (NUVB) United States $0.837B 0.00
Sionna Therapeutics (SION) United States $0.809B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Immatics (IMTX) Germany $0.806B 0.00
Oculis Holding AG (OCS) Switzerland $0.790B 0.00
CorMedix Inc (CRMD) United States $0.789B 52.91
GH Research (GHRS) Ireland $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
AnaptysBio (ANAB) United States $0.770B 0.00
Niagen Bioscience (NAGE) United States $0.761B 107.33
Ginkgo Bioworks Holdings (DNA) United States $0.756B 0.00
Upstream Bio (UPB) United States $0.752B 0.00
UniQure (QURE) Netherlands $0.749B 0.00
Vir Biotechnology (VIR) United States $0.726B 0.00
Geron (GERN) United States $0.723B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.709B 0.00
Tango Therapeutics (TNGX) United States $0.700B 0.00
ArriVent BioPharma (AVBP) United States $0.692B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.691B 0.00
Maze Therapeutics (MAZE) United States $0.689B 0.00
Dianthus Therapeutics (DNTH) United States $0.688B 0.00
Gyre Therapeutics (GYRE) United States $0.684B 182.50
Stoke Therapeutics (STOK) United States $0.682B 15.82
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.678B 0.00
NeoGenomics (NEO) United States $0.676B 0.00
Pharming Group (PHAR) Netherlands $0.676B 0.00
Zenas BioPharma (ZBIO) United States $0.671B 0.00
MeiraGTx Holdings (MGTX) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.644B 0.00
Arbutus Biopharma (ABUS) United States $0.632B 0.00
Bicara Therapeutics (BCAX) United States $0.627B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.602B 0.00
Tyra Biosciences (TYRA) United States $0.595B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.590B 0.00
Keros Therapeutics (KROS) United States $0.588B 0.00
Fortrea Holdings (FTRE) United States $0.576B 15.90
Septerna (SEPN) United States $0.568B 0.00
Rapport Therapeutics (RAPP) United States $0.563B 0.00
Kura Oncology (KURA) United States $0.551B 0.00
Solid Biosciences (SLDB) United States $0.548B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.548B 0.00
Arvinas (ARVN) United States $0.546B 0.00
Sage Therapeutics (SAGE) United States $0.545B 0.00
Rezolute (RZLT) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Prime Medicine (PRME) United States $0.515B 0.00
Terns Pharmaceuticals (TERN) United States $0.502B 0.00
MBX Biosciences (MBX) United States $0.500B 0.00
Cullinan Therapeutics (CGEM) United States $0.492B 0.00
Castle Biosciences (CSTL) United States $0.469B 31.82
ATyr Pharma (ATYR) United States $0.467B 0.00
Precigen (PGEN) United States $0.463B 0.00
PureTech Health (PRTC) United States $0.459B 0.00
Cytek Biosciences (CTKB) United States $0.456B 0.00
Gossamer Bio (GOSS) United States $0.446B 0.00
Erasca (ERAS) United States $0.439B 0.00
Compass Therapeutics (CMPX) United States $0.438B 0.00
Kamada (KMDA) Israel $0.432B 25.90
Palvella Therapeutics (PVLA) United States $0.430B 0.00
REGENXBIO (RGNX) United States $0.422B 0.00
Tectonic Therapeutic (TECX) United States $0.417B 0.00
Kodiak Sciences (KOD) United States $0.412B 0.00
Fulcrum Therapeutics (FULC) United States $0.410B 0.00
Eton Pharmaceuticals (ETON) United States $0.387B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.387B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Myriad Genetics (MYGN) United States $0.378B 0.00
Absci (ABSI) United States $0.376B 0.00
Astria Therapeutics (ATXS) United States $0.375B 0.00
Prothena (PRTA) Ireland $0.373B 0.00
Humacyte (HUMA) United States $0.368B 0.00
Neumora Therapeutics (NMRA) United States $0.354B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.354B 0.00
Emergent Biosolutions (EBS) United States $0.353B 0.00
Inhibrx Biosciences (INBX) United States $0.351B 0.21
Northwest Biotherapeutics (NWBO) United States $0.350B 0.00
Cartesian Therapeutics (RNAC) United States $0.348B 0.00
Verastem (VSTM) United States $0.346B 0.00
Abeona Therapeutics (ABEO) United States $0.345B 0.00
Olema Pharmaceuticals (OLMA) United States $0.343B 0.00
Aura Biosciences (AURA) United States $0.341B 0.00
Candel Therapeutics (CADL) United States $0.329B 0.00
Foghorn Therapeutics (FHTX) United States $0.329B 0.00
Atea Pharmaceuticals (AVIR) United States $0.325B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.324B 65.75
Rocket Pharmaceuticals (RCKT) United States $0.321B 0.00
XOMA Royalty (XOMA) United States $0.317B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.308B 0.00
Allogene Therapeutics (ALLO) United States $0.306B 0.00
Inventiva S.A (IVA) France $0.301B 0.00
Ocugen (OCGN) United States $0.301B 0.00
Neurogene (NGNE) United States $0.300B 0.00
Vor Biopharma (VOR) $0.294B 0.00
Replimune (REPL) United States $0.292B 0.00
Benitec Biopharma (BNTC) United States $0.290B 0.00
ScPharmaceuticals (SCPH) United States $0.288B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.287B 0.00
Sagimet Biosciences (SGMT) United States $0.284B 0.00
Aardvark Therapeutics (AARD) United States $0.282B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.276B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.272B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
Lifecore Biomedical (LFCR) United States $0.267B 0.00
Monopar Therapeutics (MNPR) United States $0.263B 0.00
Annexon (ANNX) United States $0.261B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.259B 0.00
Prima BioMed (IMMP) Australia $0.257B 0.00
Alpha Teknova (TKNO) United States $0.256B 0.00
Bright Minds Biosciences (DRUG) United States $0.245B 0.00
Tvardi Therapeutics (TVRD) United States $0.243B 0.00
Third Harmonic Bio (THRD) United States $0.243B 0.00
Crescent Biopharma (CBIO) United States $0.240B 0.00
Entrada Therapeutics (TRDA) United States $0.239B 7.77
Adherex Technologies (FENC) United States $0.237B 0.00
AC Immune (ACIU) Switzerland $0.236B 0.00
Codexis (CDXS) United States $0.234B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.230B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.229B 0.00
Design Therapeutics (DSGN) United States $0.226B 0.00
MaxCyte (MXCT) United States $0.226B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.225B 0.00
Cardiff Oncology (CRDF) United States $0.220B 0.00
Editas Medicine (EDIT) United States $0.217B 0.00
Adocia (ADOCY) France $0.216B 0.00
Alumis (ALMS) United States $0.215B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
GENFIT S.A (GNFT) France $0.206B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.197B 0.00
DiaMedica Therapeutics (DMAC) United States $0.197B 0.00
Semper Paratus Acquisition (TVGN) United States $0.191B 0.00
Rapt Therapeutics (RAPT) United States $0.191B 0.00
BioStem Technologies (BSEM) $0.190B 7.73
Ventyx Biosciences (VTYX) United States $0.190B 0.00
Instil Bio (TIL) United States $0.185B 0.00
Caribou Biosciences (CRBU) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.181B 0.00
CytomX Therapeutics (CTMX) United States $0.181B 4.69
Voyager Therapeutics (VYGR) United States $0.177B 0.00
EnGene Holdings (ENGN) Canada $0.176B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.173B 0.00
SELLAS Life Sciences (SLS) United States $0.169B 0.00
Kyverna Therapeutics (KYTX) United States $0.166B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.163B 0.00
Elicio Therapeutics (ELTX) United States $0.162B 0.00
Citius Oncology (CTOR) United States $0.161B 0.00
Agenus (AGEN) United States $0.161B 0.00
Alector (ALEC) United States $0.161B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Anika Therapeutics (ANIK) United States $0.160B 0.00
C4 Therapeutics (CCCC) United States $0.160B 0.00
Molecular Partners AG (MOLN) Switzerland $0.159B 0.00
Black Diamond Therapeutics (BDTX) United States $0.158B 46.33
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Puma Biotechnology (PBYI) United States $0.158B 4.13
Cellectis S.A (CLLS) France $0.156B 0.00
Greenwich LifeSciences (GLSI) United States $0.149B 0.00
Alpha Cognition (ACOG) Canada $0.148B 0.00
Nkarta (NKTX) United States $0.146B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
IO Biotech (IOBT) Denmark $0.144B 0.00
Actuate Therapeutics (ACTU) United States $0.139B 0.00
I-Mab (IMAB) United States $0.139B 0.00
Contineum Therapeutics (CTNM) United States $0.135B 0.00
Fate Therapeutics (FATE) United States $0.134B 0.00
Genelux (GNLX) United States $0.134B 0.00
Sangamo Therapeutics (SGMO) United States $0.133B 0.00
Immuneering (IMRX) United States $0.132B 0.00
Compugen (CGEN) Israel $0.132B 0.00
23andMe Holding (MEHCQ) United States $0.131B 0.00
Seer (SEER) United States $0.128B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.126B 0.00
BioHarvest Sciences (BHST) Canada $0.124B 0.00
Spero Therapeutics (SPRO) United States $0.123B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Coherus Oncology (CHRS) United States $0.117B 0.00
TuHURA Biosciences (HURA) United States $0.117B 0.00
Tenaya Therapeutics (TNYA) United States $0.115B 0.00
Skye Bioscience (SKYE) United States $0.112B 0.00
Scilex Holding (SCLX) United States $0.111B 0.00
Coya Therapeutics (COYA) United States $0.107B 0.00
Seres Therapeutics (MCRB) United States $0.106B 0.00
HilleVax (HLVX) United States $0.106B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.104B 0.00
Climb Bio (CLYM) United States $0.102B 0.00
TScan Therapeutics (TCRX) United States $0.102B 0.00
Zura Bio (ZURA) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.100B 0.00
Oncolytics Biotech (ONCY) Canada $0.099B 0.00
Connect Biopharma Holdings (CNTB) United States $0.097B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.097B 0.00
Invivyd (IVVD) United States $0.097B 0.00
OKYO Pharma (OKYO) $0.095B 0.00
Nautilus Biotechnology (NAUT) United States $0.094B 0.00
Immunic (IMUX) United States $0.094B 0.00
Adagene (ADAG) China $0.094B 0.00
Entera Bio (ENTX) Israel $0.092B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
VistaGen Therapeutics (VTGN) United States $0.089B 0.00
XBiotech (XBIT) United States $0.087B 0.00
EXoZymes (EXOZ) United States $0.085B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.084B 0.00
Whitehawk Therapeutics (WHWK) United States $0.083B 0.00
Alto Neuroscience (ANRO) United States $0.083B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
Cabaletta Bio (CABA) United States $0.080B 0.00
TELA Bio (TELA) United States $0.078B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.078B 0.00
Celularity (CELU) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
Elutia (ELUT) United States $0.076B 0.00
Immix Biopharma (IMMX) United States $0.075B 0.00
INmune Bio (INMB) United States $0.075B 0.00
CervoMed (CRVO) United States $0.073B 0.00
Sutro Biopharma (STRO) United States $0.071B 0.00
Artiva Biotherapeutics (ARTV) United States $0.071B 0.00
Forte Biosciences (FBRX) United States $0.070B 0.00
Atara Biotherapeutics (ATRA) United States $0.070B 0.00
Opus Genetics (IRD) United States $0.068B 0.00
Genenta Science S.p.A (GNTA) Italy $0.068B 0.00
MiNK Therapeutics (INKT) United States $0.067B 0.00
Oncobiologics (OTLK) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Quantum Biopharma (QNTM) Canada $0.065B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Applied Therapeutics (APLT) United States $0.063B 0.00
Biomea Fusion (BMEA) United States $0.062B 0.00
Cue Biopharma (CUE) United States $0.062B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.062B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Adicet Bio (ACET) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Precision BioSciences (DTIL) United States $0.054B 0.00
KALA BIO (KALA) United States $0.054B 0.00
CalciMedica (CALC) United States $0.053B 0.00
Adlai Nortye (ANL) Cayman Islands $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
PDS Biotechnology (PDSB) United States $0.052B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
Adverum Biotechnologies (ADVM) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
ABVC BioPharma (ABVC) United States $0.051B 0.00
Kalaris Therapeutics (KLRS) United States $0.050B 0.00
Renovaro (RENB) United States $0.050B 0.00
Aligos Therapeutics (ALGS) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.048B 0.00
Alterity Therapeutics - (ATHE) Australia $0.047B 0.00
Senti Biosciences (SNTI) United States $0.047B 0.00
PepGen (PEPG) United States $0.045B 0.00
RenovoRx (RNXT) United States $0.045B 0.00
Jasper Therapeutics (JSPR) United States $0.044B 0.00
Exicure (XCUR) United States $0.042B 0.00
Lantern Pharma (LTRN) United States $0.042B 0.00
Cognition Therapeutics (CGTX) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
Pluri (PLUR) Israel $0.040B 0.00
Shattuck Labs (STTK) United States $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.039B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.039B 0.00
Ovid Therapeutics (OVID) United States $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.038B 0.00
Clearside Biomedical (CLSD) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Dyadic (DYAI) United States $0.035B 0.00
Medicus Pharma (MDCX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.035B 0.00
Mersana Therapeutics (MRSN) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.034B 0.00
Estrella Immunopharma (ESLA) United States $0.034B 0.00
CAMP4 Therapeutics (CAMP) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
ALX Oncology Holdings (ALXO) United States $0.031B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Generation Bio (GBIO) United States $0.030B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.028B 0.00
Clene (CLNN) United States $0.028B 0.00
Rein Therapeutics (RNTX) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.027B 0.00
Femasys (FEMY) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.025B 0.00
FibroBiologics (FBLG) United States $0.024B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.024B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Aytu BioPharma (AYTU) United States $0.023B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Moleculin Biotech (MBRX) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.021B 0.00
SAB Biotherapeutics (SABS) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
BioAtla (BCAB) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Rallybio (RLYB) United States $0.020B 0.00
180 Life Sciences (ATNF) United States $0.019B 0.00
Curis (CRIS) United States $0.018B 0.00
Synlogic (SYBX) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Equillium (EQ) United States $0.014B 0.00
NextCure (NXTC) United States $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
MetaVia (MTVA) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Advanced Biomed (ADVB) United States $0.012B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IBio (IBIO) United States $0.011B 0.00
Imunon (IMNN) United States $0.011B 0.00
X4 Pharmaceuticals (XFOR) United States $0.011B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.010B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.010B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Synaptogenix (TAOX) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Mustang Bio (MBIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00